|
Cabrero M, Martin A, Briones J, Gayoso J, Jarque I, López J, Grande C, Heras I, Arranz R, Bernal T, Perez-Lopez E, López-Godino O, Conde E, Caballero D. Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial. Biol Blood Marrow Transplant. 2017 Jan;23(1):53-59. doi: 10.1016/j.bbmt.2016.10.003. Epub 2016 Oct 19. PubMed PMID: 27771496.
AÑO: 2017; IF: 4.484
|
27771496
|
Martínez-Laperche C, Buces E, Aguilera-Morillo MC, Picornell A, González-Rivera M, Lillo R, Santos N, Martín-Antonio B, Guillem V, Nieto JB, González M, de la Cámara R, Brunet S, Jiménez-Velasco A, Espigado I, Vallejo C, Sampol A, Bellón JM, Serrano D, Kwon M, Gayoso J, Balsalobre P, Urbano-Izpizua Á, Solano C, Gallardo D, Díez-Martín JL, Romo J, Buño I; GVHD/Immunotherapy Committee of the Spanish Group for Hematopoietic Transplantation. A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms. Blood Adv. 2018 Jul 24;2(14):1719-1737. doi: 10.1182/bloodadvances.2017011502. PubMed PMID: 30030270; PubMed Central PMCID: PMC6058238.
AÑO: 2018; IF: 4.584
|
|
Lopez-Corral L, Caballero-Velazquez T, Lopez-Godino O, Rosinol L, Perez-Vicente S, Fernandez-Aviles F, Krsnik I, Morillo D, Heras I, Morgades M, Rifon JJ, Sampol A, Iniesta F, Ocio EM, Martin J, Rovira M, Cabero M, Castilla-Llorente C, Ribera JM, Torres-Juan M, Moraleda JM, Martinez C, Vazquez A, Gutierrez G, Caballero D, San Miguel JF, Mateos MV, Perez-Simon JA. Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma. Biol Blood Marrow Transplant. 2019 Sep;25(9):1703-1712. doi: 10.1016/j.bbmt.2019.04.026. Epub 2019 May 3. PubMed PMID: 31054983.
AÑO: 2019; IF: 3.853
|
|
Montoro J, Chorao P, Bento L, Cabrero M, Martin C, Novelli S, Cadenas IG, Gutierrez G, Lopez-Godino O, Ferra C, Bastos-Oreiro M, Perez A, Parody R, Perez Simon JA, Yanez L, Sanchez A, Zanabili J, Varela MR, Cordoba R, Zudaire T, Jimenez-Ubieto A, Sanz J, Sureda A, Caballero D, Pinana JL; GETH and GELTAMO Group. Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors. Bone Marrow Transplant. 2021 Apr;56(4):992-996. doi: 10.1038/s41409-020-01161-1. Epub 2020 Dec 12. No abstract available. PubMed PMID: 33311593.
AÑO: 2021; IF: 5.174
|
|
Amat P, Lopez-Corral L, Goterris R, Perez A, Lopez O, Heras I, Arbona C, Viguria MC, Hernandez-Boluda JC, Martinez-Ruiz F, Martinez A, Solano C. Biomarker profile predicts clinical efficacy of extracorporeal photopheresis in steroid-resistant acute and chronic graft-vs-host disease after allogenic hematopoietic stem cell transplant. J Clin Apher. 2021 Oct;36(5):697-710. doi: 10.1002/jca.21918. Epub 2021 Jun 29. PubMed PMID: 34185332.
AÑO: 2021; IF: 2.605
|